Skip to main content

Table 3 Adverse events

From: Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer

  1. NAC Neoadjuvant chemotherapy, ALT Alanine aminotransferase, AST Aspartate aminotransferase